See more : McKesson Corporation (0JZU.L) Income Statement Analysis – Financial Results
Complete financial analysis of Ra Medical Systems, Inc. (RMED) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ra Medical Systems, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Maquia Capital Acquisition Corporation (MAQCU) Income Statement Analysis – Financial Results
- Hamama Meir Trading (1996) Ltd. (HMAM.TA) Income Statement Analysis – Financial Results
- Central Wealth Group Holdings Limited (0139.HK) Income Statement Analysis – Financial Results
- Banque Cantonale du Jura SA (BCJ.SW) Income Statement Analysis – Financial Results
- MAST Energy Developments PLC (MAST.L) Income Statement Analysis – Financial Results
Ra Medical Systems, Inc. (RMED)
About Ra Medical Systems, Inc.
Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 14.00K | 22.00K | 4.41M | 7.20M | 6.26M | 5.87M | 5.98M |
| Cost of Revenue | 161.00K | 1.56M | 5.48M | 8.85M | 4.21M | 4.17M | 3.14M |
| Gross Profit | -147.00K | -1.54M | -1.08M | -1.65M | 2.05M | 1.71M | 2.84M |
| Gross Profit Ratio | -1,050.00% | -6,990.91% | -24.45% | -22.93% | 32.78% | 29.05% | 47.49% |
| Research & Development | 6.39M | 12.25M | 9.01M | 4.53M | 2.78M | 4.52M | 1.72M |
| General & Administrative | 2.23M | 0.00 | 0.00 | 0.00 | 30.44M | 0.00 | 0.00 |
| Selling & Marketing | 1.25M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 16.25M | 15.48M | 25.97M | 51.55M | 30.44M | 14.95M | 5.32M |
| Other Expenses | 99.00K | 2.01M | 21.00K | 788.00K | 338.00K | 0.00 | 0.00 |
| Operating Expenses | 22.64M | 27.73M | 34.98M | 56.08M | 33.21M | 19.47M | 7.04M |
| Cost & Expenses | 22.80M | 29.29M | 40.46M | 64.93M | 37.42M | 23.63M | 10.17M |
| Interest Income | 0.00 | 0.00 | 129.00K | 1.04M | 352.00K | 0.00 | 0.00 |
| Interest Expense | 3.08M | 0.00 | 108.00K | 250.00K | 14.00K | 4.00K | 3.00K |
| Depreciation & Amortization | 8.77M | 1.57M | 2.37M | 1.75M | 624.00K | 218.00K | 95.00K |
| EBITDA | -18.20M | -29.27M | -36.06M | -57.73M | -31.16M | -17.54M | -4.10M |
| EBITDA Ratio | -129,971.43% | -133,027.27% | -818.59% | -801.92% | -498.00% | -298.84% | -68.66% |
| Operating Income | -26.96M | -29.27M | -36.06M | -57.73M | -31.16M | -17.76M | -4.20M |
| Operating Income Ratio | -192,578.57% | -133,027.27% | -818.59% | -801.92% | -498.00% | -302.56% | -70.25% |
| Total Other Income/Expenses | 3.00K | 2.01M | 21.00K | 788.00K | 338.00K | -4.00K | -3.00K |
| Income Before Tax | -26.86M | -27.26M | -36.04M | -56.94M | -30.82M | -17.76M | -4.20M |
| Income Before Tax Ratio | -191,871.43% | -123,895.45% | -818.12% | -790.97% | -492.60% | -302.62% | -70.30% |
| Income Tax Expense | 3.00K | 4.00K | 7.00K | 15.00K | 10.00K | 1.00K | 1.00K |
| Net Income | -26.87M | -27.26M | -36.05M | -56.96M | -30.83M | -17.77M | -4.20M |
| Net Income Ratio | -191,892.86% | -123,913.64% | -818.27% | -791.18% | -492.76% | -302.64% | -70.31% |
| EPS | -25.98 | -269.91 | -1.06K | -5.42K | -4.18K | -1.83K | -433.96 |
| EPS Diluted | -25.98 | -269.91 | -1.06K | -5.42K | -4.18K | -1.83K | -433.96 |
| Weighted Avg Shares Out | 1.03M | 101.00K | 33.98K | 10.52K | 7.38K | 9.68K | 9.68K |
| Weighted Avg Shares Out (Dil) | 1.03M | 101.00K | 33.98K | 10.52K | 7.38K | 9.68K | 9.68K |
RMED, HOOK, JZXN, ACRS, OPRA, CVAC Stock Prices Fall Intraday
The stock prices of RMED, HOOK, JZXN, ACRS, OPRA, and CVAC have fallen noticeably today. These are the details.
Chuck Royce's Firm Makes Changes to 3 Positions in May
Royce Investment Partners revealed earlier this week it reduced one position, added to another and sold out of a holding in May.
Why Did Ra Medical Systems Skyrocket Today?
Ra Medical Systems Inc. (NYSE:RMED) shares jumped higher Monday after retail traders pushed the stock higher. The stock was likely pushed as a possible short squeeze as it had a very high percentage of short sellers in the stock.
RMED Stock: 8 Things to Know About RA Medical as Retail Investors Look for the Next AMC
RA Medical (RMED) stock is rocketing higher on Monday as retail traders on Reddit seek out their next target to send soaring. The post RMED Stock: 8 Things to Know About RA Medical as Retail Investors Look for the Next...
Breaking Down Recent Reddit Target, RMED
RA Medical Systems Inc (NYSE:RMED) is shooting out of penny stock territory this morning, up 65.2% at $8.06 at last check, as the heavily shorted stock looks to be one of the latest victims of the "meme" stock craze.
RMED Stock Price: Over 50% Increase Pre-Market Explanation
The stock price of RA Medical Systems Inc (NYSEAMERICAN: RMED) increased by over 50% pre-market. This is why it happened.
RMED Stock: Over 25% Increase Intraday Explanation
The stock price of Ra Medical Systems, Inc. (NYSE American: RMED) increased by over 25% during intraday trading. This is why it happened.
Why Second Sight Medical, Lucira Health, RA Medical Are Moving Today
Second Sight Medical Products, Inc. (NASDAQ: EYES), Lucira Health, Inc. (NASDAQ: LHDX) and Ra Medical Systems, Inc. (NYSE: RMED) were among the biggest health care gainers Wednesday. Second Sight Rallies On Positive Results For Visual Prosthesis: Second Sight, which makes...
Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q1 2021 Results - Earnings Call Transcript
Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q1 2021 Results - Earnings Call Transcript
Earnings Outlook for Ra Medical Systems
Ra Medical Systems (NYSE:RMED) releases its next round of earnings this Tuesday, May 11. Here is Benzinga's essential guide to Ra Medical Systems's Q1 earnings report.
Source: https://incomestatements.info
Category: Stock Reports